This MedLibrary.org supplementary page on Toxicogenomics is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Toxicogenomics is a field of science that deals with the collection, interpretation, and storage of information about gene and protein activity within particular cell or tissue of an organism in response to toxic substances. Toxicogenomics meshes toxicology with genomics or molecular profiling, i.e. transcriptomics, proteomics and metabonomics[1][2].
This broad definition is supported by the United States Environmental Protection Agency stating that "the term "genomics" encompasses a broader scope of scientific inquiry and associated technologies than when genomics was initially considered. A genome is the sum total of all an individual organism's genes. Thus, genomics is the study of all the genes of a cell, or tissue, at the DNA (genotype), mRNA (transcriptome), or protein (proteome) levels. Genomics methodologies are expected to provide valuable insights for evaluating how environmental stressors affect cellular/tissue function and how changes in gene expression may relate to adverse effects. However, the relationships between changes in gene expression and adverse effects are unclear at this time and may likely be difficult to elucidate."[3]
The nature and complexity of the data (in volume and variability) demands highly dvelopped processes for of automated handling and storage. The analysis usually involves a wide array of bioinformatics and statistics.[4], regularly involving classification approaches[5].
In pharmaceutical Drug discovery and development toxicogenomics is used to study adverse, i.e. toxic, effects, of pharmaceutical drugs in defined model systems in order to draw conclusions on the toxic risk to patients or the environment. Both the EPA and the U.S. Food and Drug Administration currently preclude basing regulatory decision making on genomics data alone. However, they do encourage the voluntary submission of well-documented, quality genomics data. Both agencies are considering the use of submitted data on a case-by-case basis for assessment purposes (e.g., to help elucidate mechanism of action or contribute to a weight-of-evidence approach) or for populating relevant comparative databases by encouraging parallel submissions of genomics data and traditional toxicologic test results.[6]
Contents |
Public Toxicogenomics Projects
- Chemical Effects in Biological Systems (CEBS) - Project hosted by the National Institute of Environmental Health Sciences (NIEHS) building a knowledgebase of toxicology studies including study design, clinical pathology, and histopathology and toxicogenomics data.[7]
- InnoMed PredTox assessing the value of combining results from omics technologies together with the results from more conventional toxicology methods in more informed decision making in preclinical safety evaluation.[8]
- Predictive Safety Testing Consortium aiming to identify and clinically qualify safety biomarkers for regulatory use as part of the FDA's Critical Path Initiative[9]
- ToxCast program for Predicting Hazard, Characterizing Toxicity Pathways, and Prioritizing the Toxicity Testing of Environmental Chemicals at the United States Environmental Protection Agency[10]
References
- ^ The National Academies Press: Communicating Toxicogenomics Information to Nonexperts: A Workshop Summary (2005) [1]
- ^ Toxicogenomics: Principles and Applications; Ed.: H. K. Hamadeh and C. A. Afshari; Hoboken, NJ:Wiley-Liss, 2004. 361 pp. ISBN: 0-471-43417-5 [2]
- ^ EPA Interim Genomics Policy [3]
- ^ Mattes et al. Environ Health Perspect. 2004 Mar;112(4):495-505 [4]
- ^ Ellinger-Ziegelbauer et al., Mutat Res. 2008 Jan 1;637(1-2):23-39 [5]
- ^ Environ Health Perspect. 2006 March; 114(3): 420–429 [6]
- ^ Collins et al., Expert Opin. Drug Metab. Toxicol. (2007) 3(5):689-704 [7]
- ^ W.B. Mattes: Methods Mol Biol. 2008;460:221-38. [8]
- ^ W.B. Mattes: Methods Mol Biol. 2008;460:221-38. [9]
- ^ Dix et al., Toxicol Sci. 2007 Jan;95(1):5-12[10]
See also
External links
- Comparative Toxicogenomics Database - a public database that integrates toxicogenomic data for chemicals, genes, and diseases from the scientific literature.
Center for Research on Occupational and Environmental Toxicology definition by the CROET Research Centers: (Neuro)toxicogenomics and Child Health Research Center.
- InnoMed PredTox - official project website
- ToxCast - official project website
|
|||||
Courses:
Madurai Kamaraj University, Tamil Nadu offers a Msc (sub-Aqua Marine Ecology and TOXICOGENOMICS).
Wikipedia content modification information:
- This page was last modified on 12 September 2008, at 06:23.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Toxicogenomics".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.